Cardiovascular protection by DPP-4 inhibitors in preclinical studies: an updated review of molecular mechanisms.
第一作者:
Esraa M,Zakaria
第一单位:
Department of Pharmacology, Faculty of Pharmacy, Zagazig University, Zagazig, 44519, Egypt. IMZakarya@pharmacy.zu.edu.eg.
作者:
主题词
心血管疾病(Cardiovascular Diseases);糖尿病并发症(Diabetes Complications);糖尿病, 2型(Diabetes Mellitus, Type 2);二肽基肽酶4(Dipeptidyl Peptidase 4);二肽基肽酶Ⅳ抑制剂(Dipeptidyl-Peptidase IV Inhibitors);胰高血糖素样肽1(Glucagon-Like Peptide 1);葡萄糖(Glucose);人类(Humans);降血糖药(Hypoglycemic Agents);肠促胰岛素类(Incretins)
DOI
10.1007/s00210-022-02279-3
PMID
35945358
发布时间
2022-11-02
- 浏览5
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文